Grad student in the @HiebertLab @VUmedicine👩🏻‍🔬 Transcriptional control of cancer 🧬🤘🏼#firstgencollege

Nashville, TN
Joined September 2011
So excited to share the first half of my dissertation research. If you’re interested in transcription, enhancer activation, DLBCL, or B-cell biology, this one’s for you. Check it out in @CellGenomics!
1
8
415
I'm excited to announce that I'm defending on February 14th at 1 pm. See what I've uncovered about how mutations in FOXO1 contribute to B-cell lymphomas! Zoom link available; message me.
3
4
16
1,310
We have a whole box labeled dtag despair from failed cloning attempts
3
80
Hillary Layden retweeted
Has anyone updated their PRO-seq/GRO-seq adapters/sequencing primers to include dual indices for better results on the NovaSeq? Our current protocol is based on the TRUseq Small RNA kit but our core would like us to include a second index for better multiplexing. #Genomics
1
2
1
1
1,315
Hillary Layden retweeted
Check out our latest story in @MolecularCell. Our team pairs the dTAG system with deep genomic analysis to determine the spatiotemporal role of SMARCA5 in the maintenance of chromatin structure and function. bit.ly/3GNCalx
3
9
1
59
12,751
Hillary Layden retweeted
Excited to share our newest story! Our team details how the fusion transcription factor PAX3-FOXO1 regulates RNAPII pause release at a small number of genes via the recruitment of co-regulatory complexes to specific enhancer elements in aRMS cells. shorturl.at/ceFHL
1
2
14
Hillary Layden retweeted
#AACR2022 PhD candidate Susu Zhang will be presenting her work on identifying the direct targets of PAX3-FOXO1 from 9-12 in poster section 7.
🇺🇦 Two of the most intelligent, talented, kind, and amazing mentors I have at @VUMC_Vaccines are from #Ukraine. I will share some ways that they have shared with our lab for anyone interested to #SupportUkraine in this short 🧵 1/ #DonateUkraine #UkraineUnderAttack #UkraineWar
1
4
10